Biosimilars from A to Z: an in-depth introduction 5th April 2016, London, United Kingdom

There is a huge amount of interest across the industry about biosimilars. Due to a more economic price, they present a major opportunity to help control rising healthcare costs and to improve patient access to very expensive biologic treatments.
This masterclass will provide a detailed introduction of biosimilars: from analytical development, regulatory requirements to preclinical and clinical advances as well as manufacturing considerations.

The masterclass will also address aspects such as how biologics including monoclonal antibodies are developed and manufactured and the potential of biosimilars to provide access to patients which will released funds for innovative medicines.